Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 30, 2023

Rising Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for RISING, and what generic and branded alternatives to RISING drugs are available?

RISING has one hundred and ninety-four approved drugs.

Summary for Rising

US Patents:	0
Tradenames:	157
Ingredients:	153
NDAs:	194

Drugs and US Patents for Rising

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Rising	ZOLMITRIPTAN	zolmitriptan	TABLET, ORALLY DISINTEGRATING;ORAL	202855-002	Sep 20, 2019		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Rising	CLOPIDOGREL BISULFATE	clopidogrel bisulfate	TABLET;ORAL	077665-001	May 17, 2012		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Rising	OLMESARTAN MEDOXOMIL	olmesartan medoxomil	TABLET;ORAL	078276-001	Oct 26, 2016		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Rising	NIACIN	niacin	TABLET, EXTENDED RELEASE;ORAL	203742-003	Feb 22, 2019		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Rising

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Rising	SULFAMYLON	mafenide acetate	CREAM;TOPICAL	016763-001	Approved Prior to Jan 1, 1982	3,497,599	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic

Johnson and Johnson

McKinsey

Express Scripts

Mallinckrodt

Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.